BackAscendis Pharma A/S Overview

Ascendis Pharma A/S Total Liabilities

Latest total liabilities for ASND: $850M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$849.18M
↓ 33.42% YoYΔ $-426.30M vs prior year quarter

Peer trimmed avg / median

Loading

Ascendis Pharma A/S Total Liabilities History

Loading

Ascendis Pharma A/S vs. peers: Total Liabilities Comparison

Loading

Ascendis Pharma A/S Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascendis Pharma A/S (ASND) FAQ

As of the most recent data (June 2026), ASND shows a total liabilities of $850M. That compares with $1.3B in the prior-year period — down 33.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASND's total liabilities is now $850M (was $1.3B) — a 33.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ascendis Pharma A/S is outperforming or lagging.

Tracking ASND's total liabilities over time shows whether Ascendis Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $850M That compares with $1.3B in the prior-year period — down 33.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $850M) with ownership activity and broader fundamentals.

Ascendis Pharma A/S's total liabilities is $850M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.